Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1710-1492
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Subcutaneous Immunoglobulin-G Replacement Therapy with Preparations Currently Available in the United States for Intravenous or Intramuscular Use: Reasons and Regimens ; volume:1 ; number:3 ; day:15 ; month:9 ; year:2005 ; pages:1-11 ; date:9.2005
Allergy, asthma and clinical immunology ; 1, Heft 3 (15.9.2005), 1-11, 9.2005
- Urheber
-
Chouksey, Akhilesh
Duff, Kimberly
Wasserbauer, Nancy
Berger, Melvin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1710-1492-1-3-120
- URN
-
urn:nbn:de:101:1-2021080719321531777623
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chouksey, Akhilesh
- Duff, Kimberly
- Wasserbauer, Nancy
- Berger, Melvin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
SUBCUTANEOUS
German economy currently scarcely making headway
Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
SUBCUTANEOUS
German economy currently scarcely making headway
Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Correction to: Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits
Gene expression identifies metabolic and functional differences between intramuscular and subcutaneous adipocytes in cattle
Effects of the FHL2 gene on the development of subcutaneous and intramuscular adipocytes in goats
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
Comprehensive transcriptomic view of the role of the LGALS12 gene in porcine subcutaneous and intramuscular adipocytes
Switch from intravenous or intramuscular to subcutaneous hepatitis B immunoglobulin: effect on quality of life after liver transplantation
Open-label parallel dose tolerability study of three subcutaneous immunotherapy regimens in house dust mite allergic patients
Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts
SUBCUTANEOUS